Trials / Unknown
UnknownNCT06180031
Effect of Adding Magnesium Sulphate in Pericapsular Nerve Group Block
Effect of Adding Magnesium Sulphate to Bupivacaine in Ultrasound Guided Pericapsular Nerve Group Block for Post Operative Analgesia in Hip Joints Surgeries
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 62 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Our aim will be to compare the analgesic efficacy and safety of magnesium sulphate as an adjuvant to bupivacaine in pericapsular nerve group block in Hip joint surgeries. * Our primary outcome of the study: total amount of postoperative morphine consumption in the first 24h postoperative. * Our secondary outcome of the study: mean arterial blood pressure, heart rate, respiratory rate, adverse effects, block related complication, sedation score (by Ramsay sedation scale) and pain score (by Visual Analog Scale)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pericapsular nerve group block using bupivicaine and magnesium sulphate | This technique involves the deposition of the local anesthetic in the fascial plane between the psoas muscle and the superior pubic ramus |
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2025-01-01
- Completion
- 2025-03-30
- First posted
- 2023-12-22
- Last updated
- 2023-12-22
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06180031. Inclusion in this directory is not an endorsement.